My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
May 2016
PATIENT CARE AND SCIENCE
CDC Recommends Testing of Urine for Zika Virus
The Centers for Disease Control and Prevention (CDC) recently released a Morbidity and Mortality Weekly Report (MMWR) stating the preferred method for testing for Zika virus is through a urine sample. The virus is detectable for a longer period of time and at higher levels in urine than it is in blood. 
 
The CDC recommends that the real time reverse transcription-polymerase chain reaction (rRT-PCR) test can be performed up to two weeks after onset of symptoms, whereas the blood test can only detect Zika virus for about seven days after the onset of symptoms. A positive result from either specimen type is evidence of Zika virus infection. 
 
IDSA offers two email services to help members stay informed of updates from FDA and CDC. Content includes a range of topics, including drug warnings, recalls, and outbreak investigations. Recent alerts have included: 
 
 
 
 
IDSA members can sign up for these services online. (To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network [HAN] messages and/or alerts from FDA, and provide your email address and name where indicated.) 
 
Is Your Facility Experiencing Antibiotic Shortages? IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at mschang@idsociety.org.


Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
CDC Recommends Testing of Urine for Zika Virus
Proposed Regulations for LDTs: IDSA Expresses Concerns
CLINICAL PRACTICE MANAGEMENT
Are You Ready for MACRA? IDSA is Here to Help
POLICY AND ADVOCACY
House and Senate far Apart on Zika Funding, IDSA Advocacy Continues
IDSA Research Committee on Capitol Hill to Urge Action on Policy Proposals
HIVMA Leaders Promote HIV Research and ID Specialty on Capitol Hill
GLOBAL ID
Science Speaks Reports on Global Infectious Disease Responses
New Grant Funding for IDSA’s Center for Global Health Policy
New Global Center Papers on HIV and Tuberculosis
EDUCATION AND RESOURCES
Congratulations to this year’s Medical Scholars!
ABIM to Offer New MOC Option Based on Feedback
Have Questions about the New “All-In” Match Policy? We Have Answers!
CDC Now Accepting EIS Applications
IDWeek Mentorship Program
YOU AND YOUR COLLEAGUES
Members on the Move
Member Report
FROM THE PRESIDENT
What is IDSA Doing about the Future of ID?
TOP STORIES
IDSA Foundation Offers Three Research Awards in 2016
Accessing the Members-Only Section of the IDSA Website—Action Needed!
Senate Bill Threatens Medical Research at the Department of Defense
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.